Cardiac Ablation Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Cardiac Ablation Systems Market: By Product (Radiofrequency (RF) Ablation, Electrical Ablation, Cryoablation, Ultrasound Ablation, and Microwave Ablation), By Application (Cardiac Rhythm Management, Open Surgery, and Others), By End-User (Hospitals, Cardiac Centres, and Ambulatory Surgical Centers), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The cardiac ablation systems market valued at USD 957.3 million in 2021 and is expected to grow at a significant CAGR of 12.7% over 2022-2028. The increased demand for improved minimally invasive procedures, particularly in developed countries, is attributed to the market’s rise. Several advantages associated with minimally invasive procedures, such as reduced surgical complications, faster recovery, shorter hospital stays, and effective post-surgical pain management, are expected to drive patient preference for such treatments in the coming years, positively impacting market expansion. The advancement of the market would be aided by increasing public knowledge of the latest treatment options available for heart disorders. The government is introducing several programmes to raise awareness and improve cardiac disease management. Furthermore, coordinated efforts by the government and non-government groups to provide patients with cost-effective care will have an impact on procedural volume. The need for products will rise in the coming years as the number of ablation treatments rises. The high risk associated with cardiac ablation operations, as well as the current regulatory environment, are impeding the growth of the cardiac ablation system market. There will be a growing need for cardiac ablation devices as the prevalence of cardiovascular illnesses rises. The entire cardiac ablation devices system market is also influenced positively by advantageous reimbursement rules, the presence of several significant players, promising long-term survival, and a multimodal approach. Other reasons, such as decreasing radiofrequency ablation costs and ease of use, will also contribute to the global expansion of the cardiac ablation devices system market. The radiofrequency ablators segment has the most significant market share based on product. The cardiac ablation market’s radiofrequency (RF) ablators sector is expected to rise faster CAGR through 2028, owing to increased product availability. Several advantages of radiofrequency (RF) ablation, such as cost-effectiveness and rapid alleviation, are expected to drive segment expansion in the next years. Furthermore, RF ablation improves mobility, reduces the need for medicines, and provides long-term pain relief.

Recent Market Developments:

In Jan 2022, Medtronic plc a global leader in healthcare technology, has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company. Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) such as atrial fibrillation (AF). The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician needs within a growing patient population.

In Oct 202, Boston Scientific Corporation  has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition will expand the Boston Scientific electrophysiology and structural heart product portfolios to include the radiofrequency (RF) NRG® and VersaCross® Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access.

Cardiac Ablation Systems Market

MARKET SUMMARY
-
12.7% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 12.7%
  • Largest Market– Europe
  • Fastest Growing Market– North America

Cardiac Ablation Systems Market

  • The cardiac ablation systems market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The cardiac ablation systems market is segmented based on product type, function, application and geography.
Key Players
  • Boston Scientific Corporation (U.S.)
  • CONMED Corporation (U.S.)
  • St Jude MedicalInc. (U.S.)
  • CardioFocus Inc
  • Medtronic Plc (U.S.)
Cardiac Ablation Systems Market Dynamics

Increasing number of patients suffering from cardiovascular diseases including cardiac arrhythmias and technological advancements in cardiac ablation systems are the key market drivers boosting the growth of the cardiac ablation system market. Growth in new therapies, an ageing population, and market penetration, approval, acceptance, and launch of technologically improved devices will all contribute to a surge in the cardiac ablation system market. The cardiac ablation system market was further harmed by patient aversion to visiting hospitals and clinics, logistical challenges, and the temporary closure of manufacturing companies.


North-America Got Significant Share

Cardiac Ablation Systems Market

North American cardiac ablation system market held the largest revenue share in 2021, impelled by the rising burden of cardiovascular diseases. The growing patient pool is projected to augment the product demand. Additionally, higher adoption of advanced technology, rising healthcare expenditure, and the presence of leading industry leaders like Johnsons & Johnsons, Abbott, CardioFocus, etc., favorable reimbursement policies for cardiac ablation procedures, and mounting incidences of cardiac diseases will fuel the regional growth. Europe is expected to show significant CAGR in the cardiac ablation systems market owing to an increased aging population and increased cardiovascular diseases.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The cardiac ablation systems market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The cardiac ablation systems market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The cardiac ablation systems market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The cardiac ablation systems market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The cardiac ablation systems market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Cardiac Ablation Systems Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Triclosan Market is projected to expand at a CAGR of 12.7% during the forecast period.

The major players in the global cardiac ablation systems market are AngioDynamics,, Medtronic Inc, AtriCure, Inc, Biosense Webster, Inc., Teleflex Incorporated, Jude Medical Inc

North America is the fastest-growing region for Cardiac Ablation Systems Market


Report

Table Of Content

1. Executive Summary
2. Global Cardiac Ablation Systems Market Introduction
2.1. Global Cardiac Ablation Systems Market – Taxonomy
2.2. Global Cardiac Ablation Systems Market –Definitions
2.2.1. By Product
2.2.2. By Function
2.2.3. By Application
2.2.4. By Region
3. Global Cardiac Ablation Systems Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cardiac Ablation Systems Market Dynamic Factors – Impact Analysis
4. Global Cardiac Ablation Systems Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
5. Global Cardiac Ablation Systems Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Radiofrequency (RF) Ablators
5.1.1. Temperature-controlled Radiofrequency Ablators
5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2. Fluid-cooled Radiofrequency Ablators
5.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Robotic Catheter Manipulation Systems
5.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2. Electrical Ablators
5.2.1. Argon Plasma/Beam Coagulators
5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2. Irreversible Electroporation Systems
5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3. Cryoablation Devices
5.3.1. Tissue Contact Probes
5.3.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2. Tissue Spray Probes
5.3.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4. Ultrasound Ablators
5.4.1. High-intensity Focused Ultrasound Ablators
5.4.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2. Magnetic Resonance Guided Focused Ultrasound Ablators
5.4.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Ultrasound Ablation Systems
5.4.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5. Microwave Ablators
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6. Others
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6. Global Cardiac Ablation Systems Market, By Function, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Automated
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2. Conventional
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7. Global Cardiac Ablation Systems Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Cardiac Arrhythmia
7.1.1. Atrial Fibrillation and Flutter
7.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.2. Tachycardia
7.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2. Open Surgery
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8. Global Cardiac Ablation Systems Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6. Global Cardiac Ablation Systems Market – Opportunity Analysis Index, By Product, Function, Application, and Region, 2022-2028
9. North America Cardiac Ablation Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Radiofrequency (RF) Ablators
9.1.1.1. Temperature-controlled Radiofrequency Ablators
9.1.1.2. Fluid-cooled Radiofrequency Ablators
9.1.1.3. Robotic Catheter Manipulation Systems
9.1.2. Electrical Ablators
9.1.2.1. Argon Plasma/Beam Coagulators
9.1.2.2. Irreversible Electroporation Systems
9.1.3. Cryoablation Devices
9.1.3.1. Tissue Contact Probes
9.1.3.2. Tissue Spray Probes
9.1.4. Ultrasound Ablators
9.1.4.1. High-intensity Focused Ultrasound Ablators
9.1.4.2. Magnetic Resonance Guided Focused Ultrasound Ablators
9.1.4.3. Ultrasound Ablation Systems
9.1.5. Microwave Ablators
9.1.6. Others
9.2. Function Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Automated
9.2.2. Conventional
9.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Cardiac Arrhythmia
9.3.1.1. Atrial Fibrillation and Flutter
9.3.1.2. Tachycardia
9.3.2. Open Surgery
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Cardiac Ablation Systems Market Dynamics – Trends
10. Europe Cardiac Ablation Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Radiofrequency (RF) Ablators
10.1.1.1. Temperature-controlled Radiofrequency Ablators
10.1.1.2. Fluid-cooled Radiofrequency Ablators
10.1.1.3. Robotic Catheter Manipulation Systems
10.1.2. Electrical Ablators
10.1.2.1. Argon Plasma/Beam Coagulators
10.1.2.2. Irreversible Electroporation Systems
10.1.3. Cryoablation Devices
10.1.3.1. Tissue Contact Probes
10.1.3.2. Tissue Spray Probes
10.1.4. Ultrasound Ablators
10.1.4.1. High-intensity Focused Ultrasound Ablators
10.1.4.2. Magnetic Resonance Guided Focused Ultrasound Ablators
10.1.4.3. Ultrasound Ablation Systems
10.1.5. Microwave Ablators
10.1.6. Others
10.2. Function Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Automated
10.2.2. Conventional
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Cardiac Arrhythmia
10.3.1.1. Atrial Fibrillation and Flutter
10.3.1.2. Tachycardia
10.3.2. Open Surgery
10.3.3. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Cardiac Ablation Systems Market Dynamics – Trends
11. Asia-Pacific Cardiac Ablation Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Radiofrequency (RF) Ablators
11.1.1.1. Temperature-controlled Radiofrequency Ablators
11.1.1.2. Fluid-cooled Radiofrequency Ablators
11.1.1.3. Robotic Catheter Manipulation Systems
11.1.2. Electrical Ablators
11.1.2.1. Argon Plasma/Beam Coagulators
11.1.2.2. Irreversible Electroporation Systems
11.1.3. Cryoablation Devices
11.1.3.1. Tissue Contact Probes
11.1.3.2. Tissue Spray Probes
11.1.4. Ultrasound Ablators
11.1.4.1. High-intensity Focused Ultrasound Ablators
11.1.4.2. Magnetic Resonance Guided Focused Ultrasound Ablators
11.1.4.3. Ultrasound Ablation Systems
11.1.5. Microwave Ablators
11.1.6. Others
11.2. Function Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Automated
11.2.2. Conventional
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cardiac Arrhythmia
11.3.1.1. Atrial Fibrillation and Flutter
11.3.1.2. Tachycardia
11.3.2. Open Surgery
11.3.3. Others
11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Rest of Asia-Pacific
11.5. Asia-Pacific Cardiac Ablation Systems Market Dynamics – Trends
12. Latin America Cardiac Ablation Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Radiofrequency (RF) Ablators
12.1.1.1. Temperature-controlled Radiofrequency Ablators
12.1.1.2. Fluid-cooled Radiofrequency Ablators
12.1.1.3. Robotic Catheter Manipulation Systems
12.1.2. Electrical Ablators
12.1.2.1. Argon Plasma/Beam Coagulators
12.1.2.2. Irreversible Electroporation Systems
12.1.3. Cryoablation Devices
12.1.3.1. Tissue Contact Probes
12.1.3.2. Tissue Spray Probes
12.1.4. Ultrasound Ablators
12.1.4.1. High-intensity Focused Ultrasound Ablators
12.1.4.2. Magnetic Resonance Guided Focused Ultrasound Ablators
12.1.4.3. Ultrasound Ablation Systems
12.1.5. Microwave Ablators
12.1.6. Others
12.2. Function Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Automated
12.2.2. Conventional
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cardiac Arrhythmia
12.3.1.1. Atrial Fibrillation and Flutter
12.3.1.2. Tachycardia
12.3.2. Open Surgery
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Cardiac Ablation Systems Market Dynamics – Trends
13. Middle East and Africa Cardiac Ablation Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Radiofrequency (RF) Ablators
13.1.1.1. Temperature-controlled Radiofrequency Ablators
13.1.1.2. Fluid-cooled Radiofrequency Ablators
13.1.1.3. Robotic Catheter Manipulation Systems
13.1.2. Electrical Ablators
13.1.2.1. Argon Plasma/Beam Coagulators
13.1.2.2. Irreversible Electroporation Systems
13.1.3. Cryoablation Devices
13.1.3.1. Tissue Contact Probes
13.1.3.2. Tissue Spray Probes
13.1.4. Ultrasound Ablators
13.1.4.1. High-intensity Focused Ultrasound Ablators
13.1.4.2. Magnetic Resonance Guided Focused Ultrasound Ablators
13.1.4.3. Ultrasound Ablation Systems
13.1.5. Microwave Ablators
13.1.6. Others
13.2. Function Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Automated
13.2.2. Conventional
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cardiac Arrhythmia
13.3.1.1. Atrial Fibrillation and Flutter
13.3.1.2. Tachycardia
13.3.2. Open Surgery
13.3.3. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. MEA Cardiac Ablation Systems Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. AtriCureInc. (U.S.)
14.2.2. Biosense Webster Inc. (U.S.)
14.2.3. Biotronik SE & Co
14.2.4. Boston Scientific Corporation (U.S.)
14.2.5. CardioFocus Inc
14.2.6. CONMED Corporation (U.S.)
14.2.7. Medtronic Plc (U.S.)
14.2.8. St Jude MedicalInc. (U.S.)
15. Research Methodology
16. Key Assumptions and Acronyms

 


Report

Company Profile

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Avanos Medical, Inc.
  • Auris Health, Inc.
  • Olympus,
  • CONMED Corporation
  • ERBE ELEKTROMEDIZIN GMBH
  • AngioDynamics,
  • Medtronic Inc
  • AtriCure, Inc
  • Biosense Webster, Inc.
  • Teleflex Incorporated,
  • Jude Medical Inc
  • Lepu Medical Technology (Beijing) Co., Ltd
  • MicroPort Scientific Corporation.

Description

The cardiac ablation systems market valued at USD 957.3 million in 2021 and is expected to grow at a significant CAGR of 12.7% over 2022-2028. The increased demand for improved minimally invasive procedures, particularly in developed countries, is attributed to the market’s rise. Several advantages associated with minimally invasive procedures, such as reduced surgical complications, faster recovery, shorter hospital stays, and effective post-surgical pain management, are expected to drive patient preference for such treatments in the coming years, positively impacting market expansion. The advancement of the market would be aided by increasing public knowledge of the latest treatment options available for heart disorders. The government is introducing several programmes to raise awareness and improve cardiac disease management. Furthermore, coordinated efforts by the government and non-government groups to provide patients with cost-effective care will have an impact on procedural volume. The need for products will rise in the coming years as the number of ablation treatments rises. The high risk associated with cardiac ablation operations, as well as the current regulatory environment, are impeding the growth of the cardiac ablation system market. There will be a growing need for cardiac ablation devices as the prevalence of cardiovascular illnesses rises. The entire cardiac ablation devices system market is also influenced positively by advantageous reimbursement rules, the presence of several significant players, promising long-term survival, and a multimodal approach. Other reasons, such as decreasing radiofrequency ablation costs and ease of use, will also contribute to the global expansion of the cardiac ablation devices system market. The radiofrequency ablators segment has the most significant market share based on product. The cardiac ablation market’s radiofrequency (RF) ablators sector is expected to rise faster CAGR through 2028, owing to increased product availability. Several advantages of radiofrequency (RF) ablation, such as cost-effectiveness and rapid alleviation, are expected to drive segment expansion in the next years. Furthermore, RF ablation improves mobility, reduces the need for medicines, and provides long-term pain relief.

Recent Market Developments:

In Jan 2022, Medtronic plc a global leader in healthcare technology, has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company. Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) such as atrial fibrillation (AF). The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician needs within a growing patient population.

In Oct 202, Boston Scientific Corporation  has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition will expand the Boston Scientific electrophysiology and structural heart product portfolios to include the radiofrequency (RF) NRG® and VersaCross® Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access.

Reviews

There are no reviews yet.

Be the first to review “Cardiac Ablation Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX